ES2188521T3 - Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico. - Google Patents
Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico.Info
- Publication number
- ES2188521T3 ES2188521T3 ES00914133T ES00914133T ES2188521T3 ES 2188521 T3 ES2188521 T3 ES 2188521T3 ES 00914133 T ES00914133 T ES 00914133T ES 00914133 T ES00914133 T ES 00914133T ES 2188521 T3 ES2188521 T3 ES 2188521T3
- Authority
- ES
- Spain
- Prior art keywords
- medicine
- diarrhea
- regenerate
- pharmaceutical preparation
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000968 intestinal effect Effects 0.000 title abstract 3
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 208000011580 syndromic disease Diseases 0.000 title abstract 2
- 208000010643 digestive system disease Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000004232 Enteritis Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un preparado farmacéutico para uso en medicina y veterinaria para regenerar la flora intestinal o el síndrome dispéptico (colitis, diarrea, enteritis inespecífica), para la profilaxis y tratamiento de la descompensación microbiana intestinal después del uso de antibióticos, para enfermedades digestivas del recién nacido que recibe lactancia artificial y para las enfermedades digestivas de los animales de granja y mascotas, que contiene bacterias ácido lácticas vivas y caracterizado porque contiene una sal cálcica añadida y una sal de aluminio añadida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999FI000051A IT1307850B1 (it) | 1999-03-15 | 1999-03-15 | Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2188521T3 true ES2188521T3 (es) | 2003-07-01 |
Family
ID=11352845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00914133T Expired - Lifetime ES2188521T3 (es) | 1999-03-15 | 2000-03-15 | Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1162987B1 (es) |
AT (1) | ATE228001T1 (es) |
AU (1) | AU3555800A (es) |
DE (1) | DE60000825T2 (es) |
ES (1) | ES2188521T3 (es) |
IT (1) | IT1307850B1 (es) |
WO (1) | WO2000054788A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383534B1 (en) * | 2000-01-18 | 2002-05-07 | Lorin Dyrr | Mineral water composition |
KR100419132B1 (ko) | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01 |
DE10104055A1 (de) * | 2001-01-31 | 2002-08-14 | Suedzucker Ag | Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren |
WO2003013558A1 (en) * | 2001-07-30 | 2003-02-20 | Claudio De Simone | Treatment of radiation-induced diarrhea with probiotics |
US6936598B2 (en) * | 2003-11-21 | 2005-08-30 | Hill's Pet Nutrition, Inc. | Composition and method |
CA2470090A1 (fr) | 2004-06-18 | 2005-12-18 | Bio-K Plus International Inc. | Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques |
WO2006097949A1 (en) * | 2005-03-16 | 2006-09-21 | Actial Farmacêutica, Lda. | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough |
ES2277550B1 (es) * | 2005-12-21 | 2008-06-16 | Laboratorios Casen-Fleet, S.L. | Kit farmaceutico para la preparacion de una sal de hidratacion con un probiotico para bebes. |
EP2286836A4 (en) | 2008-04-17 | 2011-10-12 | Ajinomoto Kk | IMMUNOSTIMULATING AGENT |
DE102008059070B4 (de) * | 2008-11-26 | 2019-05-16 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung zur therapeutischen oder prophylaktischen Behandlung von Durchfallerkrankungen und/oder zur Aufrechterhaltung und/oder Wiederherstellung der natürlichen Darmflora, Dosiereinheit, Verpackungseinheit und Verwendung der Zusammensetzung |
FI122247B (fi) * | 2009-08-12 | 2011-10-31 | Vetcare Oy | Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi |
FR2974512B1 (fr) * | 2011-04-28 | 2013-11-08 | Roquette Freres | Composition anti-inflammatoire de l'intestin comprenant du maltitol |
EP2604123A1 (en) | 2011-12-15 | 2013-06-19 | Friesland Brands B.V. | Method and nutritional compositions for the treatment of diarrhea. |
ITMI20131467A1 (it) * | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
MA45327A (fr) | 2016-05-13 | 2019-03-20 | Sofar Spa | Utilisation de probiotiques pour améliorer l'absorption des protéines |
MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
CN108203702A (zh) * | 2016-12-20 | 2018-06-26 | 北京中科星冠生物技术股份有限公司 | 一种复合益生菌解酒饮料及其专用复合益生菌 |
CN108030096A (zh) * | 2017-12-18 | 2018-05-15 | 浙江民生健康科技有限公司 | 一种钙铁锌与益生菌组合物及其应用 |
US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI84874C (fi) * | 1989-11-02 | 1992-02-10 | Valio Meijerien | Foerfarande foer inkapsling av biologiskt aktiva aemnen, enligt metoden framstaelld kapsel, dess anvaendning och foder innehaollande den. |
FR2674755B1 (fr) * | 1991-04-05 | 1995-02-03 | Thorel Jean Noel | Nouvelles compositions medicamenteuses immunostimulatrices. |
WO1993000012A1 (en) * | 1991-06-28 | 1993-01-07 | Pioneer Hi-Bred Internatinal, Inc. | Manipulation of intestinal structure and enzymes in animals |
SE513815C2 (sv) * | 1995-08-25 | 2000-11-06 | Wasa Medicals Ab | Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet |
-
1999
- 1999-03-15 IT IT1999FI000051A patent/IT1307850B1/it active
-
2000
- 2000-03-15 AT AT00914133T patent/ATE228001T1/de not_active IP Right Cessation
- 2000-03-15 AU AU35558/00A patent/AU3555800A/en not_active Abandoned
- 2000-03-15 EP EP00914133A patent/EP1162987B1/en not_active Expired - Lifetime
- 2000-03-15 DE DE60000825T patent/DE60000825T2/de not_active Expired - Fee Related
- 2000-03-15 WO PCT/EP2000/002271 patent/WO2000054788A1/en active IP Right Grant
- 2000-03-15 ES ES00914133T patent/ES2188521T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ITFI990051A0 (it) | 1999-03-15 |
WO2000054788A1 (en) | 2000-09-21 |
IT1307850B1 (it) | 2001-11-19 |
ATE228001T1 (de) | 2002-12-15 |
AU3555800A (en) | 2000-10-04 |
ITFI990051A1 (it) | 2000-09-15 |
EP1162987B1 (en) | 2002-11-20 |
DE60000825T2 (de) | 2003-09-04 |
DE60000825D1 (de) | 2003-01-02 |
EP1162987A1 (en) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2188521T3 (es) | Preparado farmaceutico de uso en medicina y veterinaria para regenerar la flora intestinal en diarrea o sindrome dispeptico. | |
Li | Current status and prospects for in-feed antibiotics in the different stages of pork production—A review | |
Papatsiros et al. | Effect of benzoic acid and combination of benzoic acid with a probiotic containing Bacillus Cereus var. toyoi in weaned pig nutrition | |
ES2567296T3 (es) | Procedimiento para usar una cepa de Bacillus subtilis para potenciar la salud animal | |
Kritas et al. | Evaluation of probiotics as a substitute for antibiotics in a large pig nursery | |
US20200281227A1 (en) | Reducing the risk of viral infection due to viral contaminated feed | |
US20220338504A1 (en) | Feed additive compositions | |
AR098251A2 (es) | Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario | |
Henn et al. | Inclusion of porcine spray-dried plasma in broiler diets | |
ES2481918T3 (es) | Composición de huesos de dátiles para el tratamiento de animales | |
Rizzo et al. | Antimicrobial resistance and current alternatives in veterinary practice: A review | |
Hofacre et al. | Efficacy of butyric and valeric acid esters in a necrotic enteritis challenge model | |
JP2024501786A (ja) | 抗微生物剤組成物とその製造方法及びその製品 | |
ES2817623T3 (es) | Aditivo de complemento alimenticio | |
US20150351428A1 (en) | Methods and compositions for orally dosing postnatal swine | |
Nutricionales et al. | Mode of action of Bacillus subtilis and efficiency in piglet feeding | |
Chiba et al. | The therapeutic efficacy of allyl isothiocyanate in cows with bovine digital dermatitis | |
RU2157696C2 (ru) | Способ лечения скрытого мастита у коров | |
AU2003233814B2 (en) | Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain | |
RU2629814C1 (ru) | Препарат для лечения желудочно-кишечных болезней телят, протекающих с признаками диареи | |
Tabashsum et al. | Acceptable alternative growth promoters for organic farm animal production | |
Bhunia | Microbes as a tool to defend against antibiotic resistance in food animal production | |
Giannenas | Organic acids in pig and poultry nutrition | |
Chatterjee et al. | Global use of antimicrobials in food animals, emergence of antimicrobial resistance and way forward: an overview | |
Hill et al. | Case Study: Control of respiratory disease in male Holstein calves with tildipirosin and effect on health and growth from 0 to 4 months of age |